Raymond James & Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $111M | Buy |
|
|||||
|
2024
Q2 | $88.7M | Sell |
|
|||||
|
2024
Q1 | $79.8M | Sell |
|
|||||
|
2023
Q4 | $68.3M | Buy |
|
|||||
|
2023
Q3 | $60.1M | Sell |
|
|||||
|
2023
Q2 | $63M | Sell |
|
|||||
|
2023
Q1 | $65.8M | Sell |
|
|||||
|
2022
Q4 | $62.6M | Buy |
|
|||||
|
2022
Q3 | $47.9M | Sell |
|
|||||
|
2022
Q2 | $67.5M | Sell |
|
|||||
|
2022
Q1 | $82.9M | Sell |
|
|||||
|
2021
Q4 | $92.7M | Sell |
|
|||||
|
2021
Q3 | $104M | Buy |
|
|||||
|
2021
Q2 | $100M | Buy |
|
|||||
|
2021
Q1 | $77.7M | Buy |
|
|||||
|
2020
Q4 | $57M | Buy |
|
|||||
|
2020
Q3 | $47.2M | Buy |
|
|||||
|
2020
Q2 | $40.3M | Buy |
|
|||||
|
2020
Q1 | $34.5M | Buy |
|
|||||
|
2019
Q4 | $43.8M | Buy |
|
|||||
|
2019
Q3 | $34.2M | Buy |
|
|||||
|
2019
Q2 | $31.6M | Buy |
|
|||||
|
2019
Q1 | $26.7M | Buy |
|
|||||
|
2018
Q4 | $21.9M | Buy |
|
|||||
|
2018
Q3 | $19.9M | Buy |
|
|||||
|
2018
Q2 | $15.5M | Sell |
|
|||||
|
2018
Q1 | $13.4M | Sell |
|
|||||
|
2017
Q4 | $15.4M | Sell |
|
|||||
|
2017
Q3 | $18.8M | Buy |
|
|||||
|
2017
Q2 | $17M | Buy |
|
|||||
|
2017
Q1 | $14.3M | Sell |
|
|||||
|
2016
Q4 | $14.4M | Buy |
|
|||||
|
2016
Q3 | $15.2M | Buy |
|
|||||
|
2016
Q2 | $14.5M | Buy |
|
|||||
|
2016
Q1 | $8.98M | Sell |
|
|||||
|
2015
Q4 | $8.86M | Buy |
|
|||||
|
2015
Q3 | $5.13M | Buy |
|
|||||
|
2015
Q2 | $4.33M | Buy |
|
|||||
|
2015
Q1 | $3.91M | Buy |
|
|||||
|
2014
Q4 | $2.29M | Buy |
|
|||||
|
2014
Q3 | $1.82M | Sell |
|
|||||
|
2014
Q2 | $2.31M | Buy |
|
|||||
|
2014
Q1 | $2.21M | Buy |
|
|||||
|
2013
Q4 | $1.75M | Buy |
|
|||||
|
2013
Q3 | $327K | Sell |
|
|||||
|
2013
Q2 | $364K | Buy |
|